The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Neuroprotectin D1: A docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress
Open accessAbstract
Docosahexaenoic acid (DHA) is a lipid peroxidation target in oxidative injury to retinal pigment epithelium (RPE) and retina. Photoreceptor and synaptic membranes share the highest content of DHA of all cell membranes. This fatty acid is required for RPE functional integrity; however, it is not known whether specific mediators generated from DHA contribute to its biological significance. We used human ARPE-19 cells and demonstrated the synthesis of 10,17S-docosatriene [neuroprotectin D1 (NPD1)]. This synthesis was enhanced by the calcium ionophore A-23187, by IL-1beta, or by supplying DHA. Under these conditions, there is a time-dependent release of endogenous free DHA followed by NPD1 formation, suggesting that phospholipase A(2) releases the mediator's precursor. Added NPD1 potently counteracted H(2)O(2)/tumor necrosis factor alpha oxidative-stress-triggered apoptotic RPE DNA damage. NPD1 also up-regulated the antiapoptotic proteins Bcl-2 and Bcl-x(L) and decreased proapoptotic Bax and Bad expression. Moreover, NPD1 (50 nM) inhibited oxidative-stress-induced caspase-3 activation. NPD1 also inhibited IL-1beta-stimulated expression of cyclooxygenase 2 promoter transfected into ARPE-19 cells. Overall, NPD1 protected RPE cells from oxidative-stress-induced apoptosis, and we predict that it will similarly protect neurons. This lipid mediator therefore may indirectly contribute to photoreceptor cell survival as well. Because both RPE and photoreceptor cells die in retinal degenerations, our findings contribute to the understanding of retinal cell survival signaling and potentially to the development of new therapeutic strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“DHA then ends up amounting to more than 50% of OS phospholipid fatty acyl chains and therefore DHA-containing phospholipids in the retina and other cells are reservoirs for docosanoids (Bazan et al., 1984; Mukherjee et al., 2004).”
From Docosanoids and elovanoids from omega-3 fatty acids are pro-homeostatic modulators of inflammatory responses, cell damage and neuroprotection (2018) · cites this paper as Mukherjee et al., 2004
In the citing paper
“In fact, NPD1 also induces the anti-apoptotic Bcl-2 family of proteins Bcl-2 and Bcl-xl in oxidatively challenged human RPE cells (Mukherjee et al., 2004) and promotes cytoprotection.”
From Docosanoids and elovanoids from omega-3 fatty acids are pro-homeostatic modulators of inflammatory responses, cell damage and neuroprotection (2018) · cites this paper as Mukherjee et al., 2004
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Essential fatty acids in health and chronic disease
Simopoulos, A. P. (1999) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/70.3.560s · Cited by 1,703
Serhan, C. N., Clish, C. B., Brannon, J., Colgan, S. P., Chiang, N., & Gronert, K. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.8.1197 · Cited by 1,189
Self-citationHong, S., Gronert, K., Devchand, P. R., Moussignac, R.-L., & Serhan, C. N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300218200 · Cited by 1,000
Self-citationMechanisms of action of docosahexaenoic acid in the nervous system
Salem, N., Litman, B., Kim, H., & Gawrisch, K. (2001) · Lipids · doi:10.1007/s11745-001-0805-6 · Cited by 919
Neuringer, M. D., CONNOR, W. E., Lin, D. S., Barstad, L., & Luck, S. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.11.4021 · Cited by 914
Effects of ischemia and electroconvulsive shock on free fatty acid pool in the brain
Bazán, N. G. (1970) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(70)90086-x · Cited by 855
Marcheselli, V. L., Hong, S., Lukiw, W. J., Tian, X. H., Gronert, K., Musto, A., Hardy, M., Gimenez, J. M., Chiang, N., Serhan, C. N., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305841200 · Cited by 802
Self-citationDietary omega-3 fatty acid deficiency and visual loss in infant rhesus monkeys.
Neuringer, M., CONNOR, W. E., Petten, C. V., & Barstad, L. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111202 · Cited by 645
Birch, E. E., Garfield, S., Hoffman, D. R., Uauy, R. D., & Birch, D. G. (2000) · Developmental Medicine & Child Neurology · doi:10.1017/s0012162200000311 · Cited by 619
Effect of Dietary Omega-3 Fatty Acids on Retinal Function of Very-Low-Birth-Weight Neonates
Uauy, R. D., Birch, D. G., Birch, E. E., Tyson, J. E., & Hoffman, D. R. (1990) · Pediatric Research · doi:10.1203/00006450-199011000-00014 · Cited by 574
Research works printed but not linked: 10
- Bazan, N. G. (1990) in Nutrition and the Brain, eds. Wurtman, R. J. & Wurtman, J. J. (Raven, New York), Vol. 8, pp. 1-24.
- Aveldaño di Caldironi, M. I. & Bazan, N. G. (1977) Adv. Exp. Med. Biol. 83, 249-256.411344
- Organisciak, D. T., Darrow, R. M., Jiang, Y. L. & Blanks, J. C. (1996) Invest. Ophthalmol. Vis. Sci. 37, 2243-2257.8843911
- Anderson, R. E, Maude, M. B. & Bok, D. (2001) Invest. Ophthalmol. Vis. Sci. 42, 1715-1720.11431433
- Bicknell, I. R., Darrow, R., Barsalou, L., Fliesler, S. J. & Organisciak, D. T. (2002) Mol. Vis. 8, 333-340.12355060
- Anderson, R. E, Maude, M. B., McClellan, M., Matthes, M. T., Yasumura, D. & LaVail, M. M. (2002) Mol. Vis. 8, 351-358.12355064
- Hu, J. & Bok, D. (2001) Mol. Vis. 7, 14-19.11182021
- Osborne, N. N., Cazevieillem C., Pergandem, G. & Wood, J. P. (1997) Invest. Ophthalmol. Vis. Sci. 38, 1390-1400.9191602
- Liang, Y. G., Jorgensen, A. G., Kaestel, C. G., Wiencke, A. K., Lui, G. M., la Cour, M. H., Ropke, C. H. & Nissen, M. H. (2000) Curr. Eye Res. 20, 25-34.10611712
- Sparrow, J. R. & Cai, B. (2001) Invest. Ophthalmol. Vis. Sci. 42, 1356-1362.11328751
Cited by
Sorted by citations
Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators
Serhan, C. N., Chiang, N., & Van Dyke, T. E. (2008) · Nature Reviews Immunology · doi:10.1038/nri2294 · Cited by 2,932
“and neural systems that has been documented in studies by Bazan and colleague”
Self-citationResolution of inflammation: the beginning programs the end
Serhan, C. N., & Savill, J. (2005) · Nature Immunology · doi:10.1038/ni1276 · Cited by 2,552
Self-citationn−3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases
Calder, P. C. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.6.1505s · Cited by 2,525
Eicosanoid storm in infection and inflammation
Dennis, E. A., & Norris, P. C. (2015) · Nature Reviews Immunology · doi:10.1038/nri3859 · Cited by 1,517
Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators
Serhan, C. N., & Levy, B. D. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97943 · Cited by 1,344
“DHA and NPD1 are neuroprotective in the retina (128), CNS, and brain (68), and PD1/NPD1 and resolvins may protect in early-stage Alzheimer’s as well as in ischemic stroke (124, 129).”
Self-citationThe Opposing Effects of N-3 and n-6 Fatty Acids
Schmitz, G., & Ecker, J. (2008) · Progress in Lipid Research · doi:10.1016/j.plipres.2007.12.004 · Cited by 1,245
Emerging targets in neuroinflammation-driven chronic pain
Ji, R., Xu, Z., & Gao, Y. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4334 · Cited by 1,139
Serhan, C. N. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141647 · Cited by 1,020
Resolvins and protectins in inflammation resolution
Serhan, C. N., & Petasis, N. A. (2011) · Chemical Reviews · doi:10.1021/cr100396c · Cited by 996
Self-citationMaresins: Novel macrophage mediators with potent antiinflammatory and proresolving actions
Serhan, C. N., Yang, R., Martinod, K., Kasuga, K., Pillai, P. S., Porter, T. F., Oh, S. F., & Spite, M. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081880 · Cited by 908
Self-citationLukiw, W. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25420 · Cited by 897
“The unesterified DHA pool size assessed by liquid chromatography–photodiode array–electrospray ionization–tandem mass spectrometry–based (LC-PDA-ESI-MS-MS–based) lipidomic analysis (5, 6) (Figure 1I) showed that neither Aβ42 nor sAPPα was able to promote unesterFigure 2 Aβ42-induced apoptosis is inhibited by NPD1 in H…”
InfluentialAdvances in Our Understanding of Oxylipins Derived from Dietary PUFAs
Gabbs, M., Leng, S., Devassy, J. G., Monirujjaman, M., & Aukema, H. M. (2015) · Advances in Nutrition · doi:10.3945/an.114.007732 · Cited by 831
“LOX oxylipins 14,20-DiHDoHE Inhibits PMN infiltration in the mouse peritonitis model (101) 14,21-DiHDoHE Enhances wound healing in murine models (313, 314) 4-HDoHE Inhibits endothelial cell proliferation and sprouting angiogenesis in mouse model of oxygen-induced retinopathy (315) 7-HDoHE Activates PPARg in transfecte…”
Polyunsaturated fatty acids and inflammatory processes: New twists in an old tale
Calder, P. C. (2009) · Biochimie · doi:10.1016/j.biochi.2009.01.008 · Cited by 721
“Metabolism of DHA initially by 15-lipoxygenase and then a series of other reactions generates a dihydroxy derivative termed neuroprotectin D1 (also called protectin D1), again a potent antiinflammatory molecule in neutrophils, macrophages, T cells, and microglia [25,28].”
Lim, G. P., Calon, F., Morihara, T., Yang, F., Teter, B., Ubeda, O. J., Salem, N., Frautschy, S. A., & Cole, G. M. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.4225-04.2005 · Cited by 697
Connor, K. M., SanGiovanni, J. P., Löfqvist, C., Aderman, C. M., Chen, J., Higuchi, A., Hong, S., Pravda, E. A., Majchrzak, S. F., Carper, D. A., et al. (2007) · Nature Medicine · doi:10.1038/nm1591 · Cited by 687
“Furthermore, the metabolites NPD1, RvD1 and RvE1 dose-dependently reduce Tnf mRNA expression in macrophages in culture and in other inflammatory model”
Dyall, S. C., Balas, L., Bazan, N. G., Brenna, J. T., Chiang, N., Souza, F. D. C., Dalli, J., Durand, T., Galano, J., Lein, P. J., et al. (2022) · Progress in Lipid Research · doi:10.1016/j.plipres.2022.101165 · Cited by 707
“Hence, while produced and functions in neural systems, the prefix (neuro)protectin D1 was introduced [130], and in the immune system, it is PD1 [134].”
InfluentialEssential Fatty Acids: Biochemistry, Physiology and Pathology
Das, U. N. (2006) · Biotechnology Journal · doi:10.1002/biot.200600012 · Cited by 650
“These studies suggest that people who are genetically or otherwise predisposed to the disease may be able to delay it by increasing their DHA intake [79, 94].”
Polyunsaturated fatty acids and inflammation
Calder, P. C. (2006) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2006.05.012 · Cited by 660
“In addition, DHAderived mediators termed D-series resolvins, docosatrienes and neuroprotectins, also produced by COX-2/ LOX under some conditions, have been identified and these too appear to be anti-inflammatory and inflammation resolving [22–24].”
The Retinal Pigment Epithelium in Health and Disease
Sparrrow, J. R., Hicks, D., & Hamel, C. (2010) · Current Molecular Medicine · doi:10.2174/156652410793937813 · Cited by 655
Shimizu, T. (2008) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.011008.145616 · Cited by 593
Serhan, C. N. (2017) · The FASEB Journal · doi:10.1096/fj.201601222r · Cited by 566
“1) with the ABBREVIATIONS: DHA, docosahexaenoic acid; EPA, eicosapentaenoic acid; HDHA, hydroxy-docosahexaenoic acid; LC-MS-MS, liquid chromatography– tandem mass spectrometry; LOX, lipoxygenase; LT, leukotriene; LX, lipoxin; MaR, maresin; MCTR, maresin conjugate in tissue regeneration; NPD1, neuroprotectin D1; NSAID,…”
Retinal light damage: Mechanisms and protection
Organisciak, D. T., & Merriman, D. K. (2009) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2009.11.004 · Cited by 558
Chong, Z. Z., Li, F., & Maiese, K. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.02.004 · Cited by 536
Cardiovascular effects of marine omega-3 fatty acids
Saravanan, P., Davidson, N. C., Schmidt, E. B., & Calder, P. C. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60445-x · Cited by 513
Anti-Inflammatory and Proresolving Lipid Mediators
Serhan, C. N., Yacoubian, S., & Yang, R. (2008) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.3.121806.151409 · Cited by 528
Serhan, C. N., Dalli, J., Colas, R. A., Winkler, J. W., & Chiang, N. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.08.006 · Cited by 492
“Given its potent protective actions in the retina and brain, we initially termed this bioactive mediator neuroprotectin D1 (NPD1) [12,14,72].”
InfluentialAction of epoxyeicosatrienoic acids on cellular function
Spector, A. A., & Norris, A. W. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00402.2006 · Cited by 487
“Another epoxide derivative of DHA, 16,17-epoxy-docosatriene, is an intermediate in the pathway that produces neuroprotectin D1 in human ARPE-19 cells (113).”
Modulation of inflammation in brain: A matter of fat
Farooqui, A. A., Horrocks, L. A., & Farooqui, T. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04371.x · Cited by 460
Docosahexaenoic acid: A positive modulator of Akt signaling in neuronal survival
Akbar, M. D., Calderón, F. H., Wen, Z., & Kim, H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502903102 · Cited by 473
Simó, R., Villarroel, M., Corraliza, L., Hernández, C., & García‐Ramírez, M. (2010) · BioMed Research International · doi:10.1155/2010/190724 · Cited by 481
“Apart from the RPE’s functional integrity, DHA is the precursor of neuroprotectin D1 (NPD1), a docosatriene that protects RPE cells from oxidative stress [15, 16].”
Phillis, J. W., Horrocks, L. A., & Farooqui, A. A. (2006) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.02.002 · Cited by 470
Serhan, C. N., Gotlinger, K. H., Hong, S., Lu, Y., Siegelman, J. N., Baer, T. E., Yang, R., Colgan, S. P., & Petasis, N. A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1848 · Cited by 468
“, 10,17-dihydroxydocosatriene (1, 3, 37); its potent role in neural protection was recently uncovered (2), and thus it is denoted as NPD1 when produced in neural tissues.”
Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases
Calder, P. C. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700289 · Cited by 465
Bazan, N. G., Molina, M. F., & Gordon, W. C. (2011) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.012809.104635 · Cited by 441
Self-citationEndogenous pro‐resolving and anti‐inflammatory lipid mediators: a new pharmacologic genus
Serhan, C. N., & Chiang, N. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707489 · Cited by 441
“NPD1 limits stroke brain injury in part by reducing the entry of activated PMN to the stroke area (Marcheselli et al., 2003) and retinal pigmented cellular damage and promotes brain cell survival, suppressing Ab42-induced neurotoxicity (Mukherjee et al., 2004) (Table 5).”
InfluentialNovel Lipid Mediators and Resolution Mechanisms in Acute Inflammation
Serhan, C. N. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.100322 · Cited by 421
Self-citationNutrition in Brain Development and Aging: Role of Essential Fatty Acids
Uauy, R. D., & Dangour, A. D. (2006) · Nutrition Reviews · doi:10.1301/nr.2006.may.s24-s33 · Cited by 426
Natural resolution of inflammation
Freire, M., & Dyke, T. E. V. (2013) · Periodontology 2000 · doi:10.1111/prd.12034 · Cited by 414
A neuroscientist's guide to lipidomics
Piomelli, D., Astarita, G., & Rapaka, R. S. (2007) · Nature reviews. Neuroscience · doi:10.1038/nrn2233 · Cited by 399
Resolvins and protectins in the termination program of acute inflammation
Ariel, A., & Serhan, C. N. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.02.007 · Cited by 386
Farooqui, A. A., Ong, W., & Horrocks, L. A. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.7 · Cited by 378
“The generation of docosanoids may 604 FAROOQUI ET AL. be an internal protective mechanism for preventing brain damage (Horrocks and Farooqui, 2004; Mukherjee et al., 2004; Serhan et al., 2004).”
Bazan, N. G. (2006) · Brain Pathology · doi:10.1111/j.1750-3639.2005.tb00513.x · Cited by 380
“The newly isolated dihydroxy-containing DHA derivative from RPE and brain cells is called “neuroprotectin D1” (NPD1): i) because of its neuroprotective properties in brain ischemia-reperfusion (34) and in oxidative stress-challenged RPE cells (40), ii) because of its potent ability to inactivate pro-apoptotic signalin…”
InfluentialNovel Lipid Mediators Promote Resolution of Acute Inflammation
Spite, M. R., & Serhan, C. N. (2010) · Circulation Research · doi:10.1161/circresaha.110.223883 · Cited by 379
Protectin D1 Is Generated in Asthma and Dampens Airway Inflammation and Hyperresponsiveness
Levy, B. D., Kohli, P., Gotlinger, K. H., Haworth, O., Hong, S., Kazani, S. D., Israel, E., Haley, K. J., & Serhan, C. N. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.1.496 · Cited by 364
“In the nervous system, PD1 decreases brain leukocyte infiltration, IL-1 -induced NF- B activation, and cyclooxygenase-2 expression to elicit neuroprotection (12, 17).”
Cell survival matters: docosahexaenoic acid signaling, neuroprotection and photoreceptors
Bazan, N. G. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.03.005 · Cited by 353
Serhan, C. N., Arita, M., Hong, S., & Gotlinger, K. H. (2004) · Lipids · doi:10.1007/s11745-004-1339-7 · Cited by 355
“Neuroprotectin D1 Human whole blood, human PMN murine brain stroke (14) (10,17S-docosatriene) and its omega carbon-22 oxidation product, AT-RvD2 Murine inflammatory exudates (12) human glial cells (13); murine brain stroke (14); AT-RvD3 Murine inflammatory exudates (12) human retinal pigment epithelium ( 15 ) AT-RvD4…”
InfluentialAre all n-3 polyunsaturated fatty acids created equal?
Anderson, B. M., & David, W. L. (2009) · Lipids in Health and Disease · doi:10.1186/1476-511x-8-33 · Cited by 344
Resolvin D Series and Protectin D1 Mitigate Acute Kidney Injury
Duffield, J. S., Hong, S., Vaidya, V. S., Lu, Y., Fredman, G., Serhan, C. N., & Bonventre, J. V. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.5902 · Cited by 340
“PD1, also known as NPD1 when generated in neuronal tissues (41, 49), is protective in the brain (33).”
Old and new generation lipid mediators in acute inflammation and resolution
Stables, M. J., & Gilroy, D. W. (2010) · Progress in Lipid Research · doi:10.1016/j.plipres.2010.07.005 · Cited by 343
Polyunsaturated fatty acids and inflammation
Calder, P. C. (2005) · Biochemical Society Transactions · doi:10.1042/bst0330423 · Cited by 341
Chiang, N., & Serhan, C. N. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.03.005 · Cited by 338
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript MaR1 maresin 1 (7R, 14S-dihydroxy-docosa-4Z, 8E, 10E, 12Z, 16Z, 19Z-hexaenoic acid) PD protectin PD1 protectin D1 (10R, 17S-dihydroxy-docosa-4Z, 7Z, 11E, 13E, 15Z, 19Z-hexaenoic acid), also known as neuroprotectin D1 (NPD1) Rv resolving Rv…”
Serhan, C. N., Gotlinger, K. H., Hong, S., & Arita, M. (2004) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2004.03.005 · Cited by 317
Neurological Benefits of Omega-3 Fatty Acids
Dyall, S. C., & Michael-Titus, A. T. (2008) · NeuroMolecular Medicine · doi:10.1007/s12017-008-8036-z · Cited by 323
“It has been shown that under certain conditions DHA can be metabolised to oxygenated compounds with anti-inflammatory properties, such as 10-17S-docosatriene (also called neuroprotectin D-1 or NPD1) (Mukherjee et al. 2004) and 7,17S-dihydroperoxy-DHA (Butovich et al.”
Gronert, K., Maheshwari, N., Khan, N. A., Hassan, I., Dunn, M. W., & Schwartzman, M. L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410638200 · Cited by 312
Oxidative stress and diabetes mellitus
Yang, H., Jin, X., Lam, C. W. K., & Yan, S.-K. (2011) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2011.250 · Cited by 315
Resolvins and protectins: mediating solutions to inflammation
Kohli, P., & Levy, B. D. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00290.x · Cited by 304
“In this disorder, levels of DHA, NPD1 and 15-LOX are selectively decreased in the hippocampus, providing a plausible mechanism for decreased neuroprotection in Alzheimer’s disease; that being less inhibition of apoptosis and subsequently, increased neuronal cell death (Marcheselli et al., 2003; Mukherjee et al., 2004;…”
InfluentialTranscriptomic analyses of murine resolution-phase macrophages
Stables, M. J., Shah, S. H., Camon, E. B., Lovering, R. C., Newson, J., Byström, J., Farrow, S. N., & Gilroy, D. W. (2011) · Blood · doi:10.1182/blood-2011-04-345330 · Cited by 291
DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation
Duvall, M. G., & Levy, B. D. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.11.001 · Cited by 301
“Protectin D1 is active in human retinal pigment epithelial cells to protect against oxidative stress-induced apoptosis (Mukherjee et al., 2004) and in glial cells to block cytokine production (Hong et al., 2003).”
(2007) · Archives of Ophthalmology · doi:10.1001/archopht.125.5.671 · Cited by 283
“08) 1 medium serving/wk 69 (11) 134 (12) 0.”
Identification of a Lipase-linked Cell Membrane Receptor for Pigment Epithelium-derived Factor
Notari, L., Baladrón, V., Aroca‐Aguilar, J., Balko, N., Heredia, R. J., Meyer, C., Notario, P. M., Saravanamuthu, S. S., Nueda, M., Sánchez‐Sánchez, F., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600353200 · Cited by 283
Alessandri, J., Guesnet, P., Vancassel, S., Astorg, P., Denis, I., Goustard, B., Aïd, S., Poumès‐Ballihaut, C., Champeil‐Potokar, G., & Lavialle, M. (2004) · annales de biologie animale biochimie biophysique · doi:10.1051/rnd:2004063 · Cited by 298
“Very recently, they have shown that the 10,17S-docosatriene molecule, so called “neuroprotectin D1” (NPD1), is synthesised by human retinal pigment epithelial cells treated with a calcium ionophore or with DHA [109].”
Novel Anti-Inflammatory-Pro-Resolving Mediators and Their Receptors
Serhan, C. N., Krishnamoorthy, S., Recchiuti, A., & Chiang, N. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026611109060629 · Cited by 281
Marszalek, J. R., & Lodish, H. F. (2005) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.21.122303.120624 · Cited by 270
Weylandt, K. H., Chiu, C., Gomolka, B., Waechter, S. F., & Wiedenmann, B. (2012) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2012.01.005 · Cited by 273
Bazan, N. G. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800068-jlr200 · Cited by 256
Self-citationDifferential immunomodulation with long-chainn-3 PUFA in health and chronic disease
Sijben, J., & Calder, P. C. (2007) · Proceedings of The Nutrition Society · doi:10.1017/s0029665107005472 · Cited by 251
“…mediators D-series resolvins, docosatrienes and neuroprotectins, also produced by cyclooxygenase-2 and lipoxygenase under some conditions, have been identified that also appear to be antiinflammatory and inflammation resolving (Hong et al. 2003; Marcheselli et al. 2003; Mukherjee et al. 2004).”
Ariel, A., Li, P., Wang, W., Tang, W.-X., Fredman, G., Hong, S., Gotlinger, K. H., & Serhan, C. N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509796200 · Cited by 254
Dumbleton, K., Caffery, B. E., Doğru, M., Hickson-Curran, S. B., Kern, J. R., Kojima, T., Morgan, P. B., Purslow, C., Robertson, D. M., & Nelson, J. D. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-13125 · Cited by 245
Fetal Inflammatory Response and Brain Injury in the Preterm Newborn
Malaeb, S. N., & Dammann, O. (2009) · Journal of Child Neurology · doi:10.1177/0883073809338066 · Cited by 245
“Neuroprotectin D1 (NPD1) is a messenger with antiapoptotic properties that can inhibit upstream signaling of the apoptotic cascade.(104) Interleukin-1-b enhances neuroprotectin D1 synthesis(105) and may offer cytoprotection to cells adjacent to the site of ongoing neuroinflammation.”
Zhao, Y., Calon, F., Julien, C., Winkler, J. W., Petasis, N. A., Lukiw, W. J., & Bazan, N. G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015816 · Cited by 243
“*p,0.05; ** p,0.01 (ANOVA). doi:10.1371/journal.pone.0015816.g001 PLoS ONE | www.plosone.org 2 January 2011 | Volume 6 | Issue 1 | e15816 Plasmid Constructs and Transient Transfection of HNG Cells Plasmid containing APP695 cDNA bearing the Swedish mutation APPsw (Swedish double mutation APP695sw, K595N, M596L) was a g…”
InfluentialSelf-citationCalon, F., Lim, G. P., Morihara, T., Yang, F., Ubeda, O. J., Salem, N., Frautschy, S. A., & Cole, G. M. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04253.x · Cited by 253
“DHA-mediated reduction of the levels of Bad such as we report here has been observed in vitro as a direct effect of neuroprotective enzymatic metabolites of DHA (Mukherjee et al., 2004).”
Omega-3 fatty acids, pro-inflammatory signaling and neuroprotection
Bazan, N. G. (2007) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32802b7030 · Cited by 252
Park, C.-K., Lü, N., Xu, Z.-Z., Liu, T., Serhan, C. N., & Ji, R.-R. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.2443-11.2011 · Cited by 241
“Given the potent protective actions of this DHA-derived mediator it was coined neuroprotectin D1 (Mukherjee et al., 2004; Lukiw et al., 2005).”
Self-citationAhmmed, M. K., Ahmmed, F., Tian, H. S., Carne, A., & Bekhit, A. E. A. (2019) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12510 · Cited by 254
He, C., Qu, X., Cui, L., Wang, J., & Kang, J. X. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904835106 · Cited by 233
Novel eicosanoid and docosanoid mediators: resolvins, docosatrienes, and neuroprotectins
Serhan, C. N. (2005) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-200503000-00003 · Cited by 227
González‐Périz, A., Planagumà, A., Gronert, K., Miquel, R., López‐Parra, M., Titos, E., Horrillo, R., Ferré, N., Deulofeu, R., Arroyo, V., et al. (2006) · The FASEB Journal · doi:10.1096/fj.06-6250fje · Cited by 230
“In fact, PD1 has been shown to decrease COX-2 mRNA expression, block NFB activation in the mouse hippocampus as well as in neural cells in culture (10), and inhibit IL-1-induced COX-2 expression in human retinal pigment epithelial cells ( 38 ).”
Massaro, M., Habib, A., Lubrano, L., Turco, S. D., Lazzerini, G., Bourcier, T., Weksler, B. B., & Caterina, R. D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510086103 · Cited by 221
Astarita, G., Jung, K.-M., Berchtold, N. C., Nguyen, V. Q., Gillen, D. L., Head, E., Cotman, C. W., & Piomelli, D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012538 · Cited by 218
“The polyunsaturated lipid, docosahexaenoic acid (C22:6n-3), is an essential component of neuronal membranes [4,5] and a precursor for potent neuroprotective mediators [6–8].”
The effects of PEDF on cancer biology: mechanisms of action and therapeutic potential
Becerra, S. P., & Notario, V. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3484 · Cited by 211
Lipoxins and new lipid mediators in the resolution of inflammation
Schwab, J. M., & Serhan, C. N. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.02.006 · Cited by 208
King, V. R., Huang, W. L., Dyall, S. C., Curran, O. E., Priestley, J. V., & Michael-Titus, A. T. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.5539-05.2006 · Cited by 207
“In addition, it has been shown that DHA can lead to the formation of mediators such as 10,17S-docosatriene (neuroprotectin D1), an endogenous compound with anti-oxidant (Bazan, 2005) as well as anti-inflammatory (Mukherjee et al., 2004) effects.”
Brain docosahexaenoic acid uptake and metabolism
Lacombe, R. J. S., Chouinard‐Watkins, R., & Bazinet, R. P. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.12.004 · Cited by 225
Carcinogenesis: Failure of resolution of inflammation?
Fishbein, A., Hammock, B. D., Serhan, C. N., & Panigrahy, D. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107670 · Cited by 218
“The Serhan laboratory utilized lipid mediator metabololipidomics, proteomics (liquid chromatography–tandem mass spectrometry [LC-MS/MS]), and cell trafficking in self-limited exudates to identify three more new families of pro-resolving mediators, termed the “resolvins” (short for resolution phase interaction products…”
Pro-Resolving Lipid Mediators Improve Neuronal Survival and Increase Aβ42 Phagocytosis
Zhu, M., Wang, X., Hjorth, E., Colas, R. A., Schroeder, L., Granholm, A.-C., Serhan, C. N., & Schultzberg, M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9544-0 · Cited by 204
“PD1 was shown to protect retinal and neuronal cells through an increase in the antiapoptotic Bcl-2 family, decreasing pro-apoptotic Bax and Bad expression, thus inhibiting caspase-3 activation [4, 61, 62] and stimulating the PI3K/Akt and mTOR/p70S6K pathways, which are supportive for cell survival [63].”
Self-citationDocosahexaenoic acid (DHA), a fundamental fatty acid for the brain: New dietary sources
Echeverría, F., Valenzuela, R., Hernández‐Rodas, M. C., & Valenzuela, A. (2017) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2017.08.001 · Cited by 220
“Experimentally the formation of NPD-1 is stimulated by various factors, highlighting; i) the increase in oxidative stress induced by H2O2; ii) the presence of tumor necrosis factor-alpha (TNF-α) and interleukin 1-beta (IL-1β) and; iii) during brain ischemia-reperfusion episodes [78,80,81].”
Brenna, J. T., & Diau, G. (2007) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2007.10.016 · Cited by 202
“This seems reasonable given that ARA serves as a substrate for synthesis of an array of highly bioactive eicosanoids, though it should be noted that DHA is also coming to be understood as a substrate for bioactive compounds [24].”
Oliver, L., Dietrich, T., Marañón, I., Villarán, M. C., & Barrio, R. J. (2020) · Resources · doi:10.3390/resources9120148 · Cited by 198
Diau, G., Hsieh, A. T., Sarkadi‐Nagy, E., Wijendran, V., Nathanielsz, P. W., & Brenna, J. T. (2005) · BMC Medicine · doi:10.1186/1741-7015-3-11 · Cited by 199
“Several hypotheses have been proposed to explain the molecular role of DHA, including its high degree of molecular flexibility as a component of membrane phospholipids [8], improvement of G-protein-coupled signaling [9,10], more favorable interaction with integral membrane proteins [11], its ability as a free fatty ac…”
Oral infections and cardiovascular disease
Kholy, K. E., Genco, R. J., & Dyke, T. E. V. (2015) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2015.03.001 · Cited by 201
Lipid signaling: Sleep, synaptic plasticity, and neuroprotection
Chen, C., & Bazan, N. G. (2005) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2005.07.001 · Cited by 193
Oxidative stress and reactive oxygen species: a review of their role in ocular disease
Ung, L., Pattamatta, U., Carnt, N. A., Wilkinson‐Berka, J. L., Liew, G., & White, A. J. R. (2017) · Clinical Science · doi:10.1042/cs20171246 · Cited by 196
Pathological role of hypoxia in Alzheimer's disease
Zhang, X., & Le, W. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.07.033 · Cited by 190
“The production of ROS, such as peroxynitrite and nitric oxide (NO), can cause the peroxidation of cellular membrane lipids (Mukherjee et al., 2004; Siu and To, 2002), the cleavage of DNA (Lee et al.”
SanGiovanni, J. P., Agrón, E., Meleth, A. D., Reed, G. F., Sperduto, R. D., Clemons, T. E., & Chew, E. Y. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.27594 · Cited by 186
Lipids and Lipidomics in Brain Injury and Diseases
Rao, A. M., Hatcher, J. F., & Dempsey, R. J. (2006) · The AAPS Journal · doi:10.1007/bf02854902 · Cited by 196
Mechanistic Insights Into Diabetes Mellitus and Oxidative Stress
Maiese, K., Chong, Z. Z., & Shang, Y. C. (2007) · Current Medicinal Chemistry · doi:10.2174/092986707781058968 · Cited by 186
Barker, F. M., Snodderly, D. M., Johnson, E. J., Schalch, W., Koepcke, W., Gerß, J., & Neuringer, M. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-5898 · Cited by 182
Lipid metabolism in inflammation-related diseases
Zhang, C., Wang, K., Yang, L., Liu, R., Chu, Y., Qin, X. Y., Yang, P., & Yu, H. (2018) · The Analyst · doi:10.1039/c8an01046c · Cited by 180
Barbosa, M., Valentão, P., & Andrade, P. (2014) · Marine Drugs · doi:10.3390/md12094934 · Cited by 181
“Moreover, NPD1 inhibited oxidative-stress-induced caspase-3 activation and IL-1-stimulated expression of COX-2 [163].”
InfluentialLipid Mediators in Inflammation
Bennett, M., & Gilroy, D. W. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.mchd-0035-2016 · Cited by 195
“In disease states, PD1 has been proven to be protective in experimental models of ischemic stroke (109), oxidative stress (304 – 306), asthma (302), ischemia/reperfusion renal injury (301), and Alzheimer ’ s disease (307).”
Metadata
- Authors
- Mukherjee, P. K., Marcheselli, V. L., Serhan, C. N., & Bazan, N. G.
- Affiliations
- Louisiana State University (US)
- Corresponding author
- Bazan, Nicolas G.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2004-05-19
- Volume
- 101
- Issue
- 22
- Pages
- 8491-8496
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC420421
- OpenAlex
- W1739691545
- Cited by
- 753
- References
- 50
- Citations by year
- 2026: 22 · 2025: 14 · 2024: 13 · 2023: 14 · 2022: 24 · 2021: 20 · 2020: 34 · 2019: 23 · 2018: 25 · 2017: 34 · 2016: 24 · 2015: 35 · 2014: 42 · 2013: 52 · 2012: 42
- FWCI
- 44.10
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Huntsman Cancer Institute
- University of Leicester
- National Institutes of Health (4r37gm038765-19, GM 38765)
- National Eye Institute (EY05121, R01EY005121)
- National Institute of General Medical Sciences (GM 38765, R01GM038765, R37-GM038765)
- National Center for Research Resources (P20RR-16816, P20RR016816)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Keywords
- neuroprotectin D1, docosahexaenoic acid, retinal pigment epithelium, oxidative stress, apoptosis, phospholipase A2, cyclooxygenase-2, Bcl-2 family proteins, caspase-3, IL-1β, photoreceptor survival, retinal degeneration, lipid mediators
- MeSH terms
- Cell Line, Docosahexaenoic Acids, Epithelial Cells, Humans, Interleukin-1, Isoenzymes, Membrane Proteins, Pigment Epithelium of Eye, Prostaglandin-Endoperoxide Synthases, Lipid Peroxidation, Molecular Structure, Apoptosis, Oxidative Stress, Proto-Oncogene Proteins c-bcl-2, Caspases, Cyclooxygenase 2, Caspase 3, DNA Fragmentation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review